N1VS34:BVMF
Novartis
72,10 BRL
0,00%
(0,00) 1D
9. okt., 16:56:00 GMT -3 · BRL
search
Vsi simboli
| Simbol | Cena | Sprememba | Odstotna sprememba |
|---|
insights_autoGeneriranje najpomembnejših vpogledov za N1VS34 …
Odpri
71,68 BRL
Visoka
72,10 BRL
Nizka
71,68 BRL
Tržna kapitalizacija
292,13 mrd.
Povprečni promet
200,00
Promet
64,00
52-tedenski najvišji tečaj
87,30 BRL
52-tedenski najnižji tečaj
65,03 BRL
Št. izdanih delnic
2,03 mrd.
Št. zaposlenih
75 tis.
Odpri
71,68 BRL
Visoka
72,10 BRL
Nizka
71,68 BRL
Tržna kapitalizacija
292,13 mrd.
Povprečni promet
200,00
Promet
64,00
52-tedenski najvišji tečaj
87,30 BRL
52-tedenski najnižji tečaj
65,03 BRL
Št. izdanih delnic
2,03 mrd.
Št. zaposlenih
75 tis.
Novice
Iz spletnih virov in novičarskih partnerjev
Forkast News
·
pred 10 urami
SAP’s Joule Assistants Are Now Executing Inside Production Business Workflows at Novartis, Nestlé, and PwC
marketscreener.com
·
pred 11 urami
Swiss Blue-chip Index Starts Week Upbeat; Roche, Novartis Shares Gain
IAM Patent
·
pred 18 urami
Novartis inks $7.8 billion mRNA deal with Chinese company Abogen
TradingView
·
pred 23 urami
Weekly Recap: Abogen mRNA T‑cell engager investment and Rhapsido approval
Profil
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024.
Novartis manufactures the drugs clozapine, diclofenac, carbamazepine, valsartan, imatinib mesylate, cyclosporine, letrozole, methylphenidate, terbinafine, deferasirox, and others.
Novartis was formed in 1996 by the merger of Ciba-Geigy and Sandoz. It was considered the largest corporate merger in history during that time. The pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. The name Novartis was based on the Latin terms, novae artes.
After the merger, other Ciba-Geigy and Sandoz businesses were sold, or, like Ciba Specialty Chemicals, spun off as independent companies. The Sandoz brand disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz. Wikipedia
Vizitka: Novartis
Generalni direktorVasant Narasimhan
Št. zaposlenih75,3 tis.
Ustanovljeno7. mar. 1996
SedežBasel, Basel, Švica
Sektor-
Spletno mestonovartis.com